Atypical antipsychotic agents in the treatment of Schizophrenia and other psychiatric disorders. Part II: Special considerations.
D014150:Antipsychotic Agents / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D001714:Bipolar Disorder / Q000188:drug therapy; D003024:Clozapine / Q000627:therapeutic use; D003362:Cost-Benefit Analysis; D016527:Drug Costs; D017048:Health Care Costs; D006801:Humans; D001523:Mental Disorders / Q000188:drug therapy* / Q000191:economics; D012559:Schizophrenia / Q000188:drug therapy* / Q000191:economics
D014150:Antipsychotic Agents; D003024:Clozapine